Literature DB >> 29451705

Modeling asthma: Pitfalls, promises, and the road ahead.

Helene F Rosenberg1, Kirk M Druey2.   

Abstract

Asthma is a chronic, heterogeneous, and recurring inflammatory disease of the lower airways, with exacerbations that feature airway inflammation and bronchial hyperresponsiveness. Asthma has been modeled extensively via disease induction in both wild-type and genetically manipulated laboratory mice (Mus musculus). Antigen sensitization and challenge strategies have reproduced numerous important features of airway inflammation characteristic of human asthma, notably the critical roles of type 2 T helper cell cytokines. Recent models of disease induction have advanced to include physiologic aeroallergens with prolonged respiratory challenge without systemic sensitization; others incorporate tobacco, respiratory viruses, or bacteria as exacerbants. Nonetheless, differences in lung size, structure, and physiologic responses limit the degree to which airway dynamics measured in mice can be compared to human subjects. Other rodent allergic airways models, including those featuring the guinea pig (Cavia porcellus) might be considered for lung function studies. Finally, domestic cats (Feline catus) and horses (Equus caballus) develop spontaneous obstructive airway disorders with clinical and pathologic features that parallel human asthma. Information on pathogenesis and treatment of these disorders is an important resource. ©2018 Society for Leukocyte Biology.

Entities:  

Keywords:  airways; eosinophils; inflammation; leukocytes; veterinary

Mesh:

Year:  2018        PMID: 29451705      PMCID: PMC6134392          DOI: 10.1002/JLB.3MR1117-436R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  93 in total

Review 1.  Update on feline asthma.

Authors:  Julie E Trzil; Carol R Reinero
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-09-12       Impact factor: 2.093

Review 2.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

Review 3.  IL-4 and IL-13 signaling in allergic airway disease.

Authors:  Naina Gour; Marsha Wills-Karp
Journal:  Cytokine       Date:  2015-06-09       Impact factor: 3.861

4.  Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.

Authors:  W E Geslewitz; C M Percopo; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2017-11-22       Impact factor: 5.018

Review 5.  Identification of IgE.

Authors:  Kimishige Ishizaka; Teruko Ishizaka
Journal:  J Allergy Clin Immunol       Date:  2016-04-15       Impact factor: 10.793

Review 6.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

7.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.

Authors:  Michelle M Simon; Simon Greenaway; Jacqueline K White; Helmut Fuchs; Valérie Gailus-Durner; Sara Wells; Tania Sorg; Kim Wong; Elodie Bedu; Elizabeth J Cartwright; Romain Dacquin; Sophia Djebali; Jeanne Estabel; Jochen Graw; Neil J Ingham; Ian J Jackson; Andreas Lengeling; Silvia Mandillo; Jacqueline Marvel; Hamid Meziane; Frédéric Preitner; Oliver Puk; Michel Roux; David J Adams; Sarah Atkins; Abdel Ayadi; Lore Becker; Andrew Blake; Debra Brooker; Heather Cater; Marie-France Champy; Roy Combe; Petr Danecek; Armida di Fenza; Hilary Gates; Anna-Karin Gerdin; Elisabetta Golini; John M Hancock; Wolfgang Hans; Sabine M Hölter; Tertius Hough; Pierre Jurdic; Thomas M Keane; Hugh Morgan; Werner Müller; Frauke Neff; George Nicholson; Bastian Pasche; Laura-Anne Roberson; Jan Rozman; Mark Sanderson; Luis Santos; Mohammed Selloum; Carl Shannon; Anne Southwell; Glauco P Tocchini-Valentini; Valerie E Vancollie; Henrik Westerberg; Wolfgang Wurst; Min Zi; Binnaz Yalcin; Ramiro Ramirez-Solis; Karen P Steel; Ann-Marie Mallon; Martin Hrabě de Angelis; Yann Herault; Steve D M Brown
Journal:  Genome Biol       Date:  2013-07-31       Impact factor: 13.583

8.  Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities.

Authors:  Erika Jensen-Jarolim; Lukas Einhorn; Ina Herrmann; Johann G Thalhammer; Lucia Panakova
Journal:  Clin Transl Allergy       Date:  2015-04-07       Impact factor: 5.871

Review 9.  Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?

Authors:  Ann Kristin Barton; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

Review 10.  Development of New Therapies for Severe Asthma.

Authors:  Merritt L Fajt; Sally E Wenzel
Journal:  Allergy Asthma Immunol Res       Date:  2017-01       Impact factor: 5.764

View more
  9 in total

1.  Lung eosinophilia induced by house dust mites or ovalbumin is modulated by nicotinic receptor α7 and inhibited by cigarette smoke.

Authors:  Lorise C Gahring; Elizabeth J Myers; Diane M Dunn; Robert B Weiss; Scott W Rogers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-05       Impact factor: 5.464

2.  Age-Dependent Reduction in Asthmatic Pathology through Reprogramming of Postviral Inflammatory Responses.

Authors:  Guy Hazan; Anna Eubanks; Carrie Gierasch; Jeffrey Atkinson; Carolyn Fox; Ariel Hernandez-Leyva; Anne L Rosen; Andrew L Kau; Eugene Agapov; Jennifer Alexander-Brett; Deborah Steinberg; Diane Kelley; Michael White; Derek Byers; Kangyun Wu; Shamus P Keeler; Yong Zhang; Jeffrey R Koenitzer; Elise Eiden; Neil Anderson; Michael J Holtzman; Jeffrey Haspel
Journal:  J Immunol       Date:  2022-02-16       Impact factor: 5.422

Review 3.  Different Phenotypes in Asthma: Clinical Findings and Experimental Animal Models.

Authors:  Luiz Otávio Lourenço; Alessandra Mussi Ribeiro; Fernanda Degobbi Tenório Quirino Dos Santos Lopes; Iolanda de Fátima Lopes Calvo Tibério; Wothan Tavares-de-Lima; Carla Máximo Prado
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-20       Impact factor: 8.667

Review 4.  Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?

Authors:  Inês Esteves Dias; Pedro Olivério Pinto; Luís Carlos Barros; Carlos Antunes Viegas; Isabel Ribeiro Dias; Pedro Pires Carvalho
Journal:  BMC Vet Res       Date:  2019-10-22       Impact factor: 2.741

5.  Effects of azithromycin on bronchial remodeling in the natural model of severe neutrophilic asthma in horses.

Authors:  Sophie Mainguy-Seers; Roxane Boivin; Sheila Pourali Dogaheh; Francis Beaudry; Pierre Hélie; Alvaro G Bonilla; James G Martin; Jean-Pierre Lavoie
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

6.  Temporal changes of the respiratory microbiota as cats transition from health to experimental acute and chronic allergic asthma.

Authors:  Aida I Vientós-Plotts; Aaron C Ericsson; Zachary L McAdams; Hansjorg Rindt; Carol R Reinero
Journal:  Front Vet Sci       Date:  2022-08-25

Review 7.  T cells in severe childhood asthma.

Authors:  Alberta G A Paul; Lyndsey M Muehling; Jacob D Eccles; Judith A Woodfolk
Journal:  Clin Exp Allergy       Date:  2019-04-04       Impact factor: 5.018

Review 8.  The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Hans-Uwe Simon; Shida Yousefi; Nina Germic; Isabelle C Arnold; Angela Haczku; Alexander V Karaulov; Dagmar Simon; Helene F Rosenberg
Journal:  Int Arch Allergy Immunol       Date:  2019-11-29       Impact factor: 2.749

9.  Development and Characterization of an Allergic Asthma Rat Model for Interventional Studies.

Authors:  Marta Périz; Francisco J Pérez-Cano; Maria J Rodríguez-Lagunas; Trinitat Cambras; Santiago Pastor-Soplin; Iván Best; Margarida Castell; Malén Massot-Cladera
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.